SQA
IMGN

Simon Quick Advisors’s Immunogen Inc IMGN Stock Holding History

Simon Quick Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,000
Closed -$191K – 603
2017
Q3 		$191K Hold
25,000
– – 0.07% 135
2017
Q2 		$178K Hold
25,000
– – 0.1% 73
2017
Q1 		$97K Buy
+25,000
New +$73K 0.06% 118

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simon Quick Advisors's IMGN Position: Q4 2017 in Review

Simon Quick Advisors sold out of Immunogen Inc (IMGN) in Q4 2017, closing a stake of 25,000 shares — an estimated $191K sold.

Simon Quick Advisors first reported a position in IMGN in Q1 2017 and held it in 3 quarters. The position peaked at $191K in Q3 2017. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Simon Quick Advisors reported no remaining Immunogen Inc position as of Q4 2017 after selling out during the quarter.
  • Simon Quick Advisors sold 25,000 Immunogen Inc shares in Q4 2017, an estimated $191K.
  • Simon Quick Advisors first reported a position in Immunogen Inc in Q1 2017 and held it in 3 quarters.
  • Simon Quick Advisors's Immunogen Inc position peaked at $191K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Simon Quick Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.